Literature DB >> 7876220

Arginine 132 of cellular retinoic acid-binding protein (type II) is important for binding of retinoic acid.

L X Chen1, Z P Zhang, A Scafonas, R C Cavalli, J L Gabriel, K J Soprano, D R Soprano.   

Abstract

Cellular retinoic acid-binding protein type II (CRABP-II) is one of two small molecular weight, cytosolic proteins which specifically bind retinoic acid (RA). Crystallographic and site-directed mutagenesis studies of several related proteins have indicated that either one or two conserved amino acid residues, homologous to positions Arg111 and Arg132 of CRABP-II, are important for the binding of the hydrophobic ligand. In this report we have prepared site-directed mutations of these two positions of CRABP-II, Arg111 and Arg132, as well as Lys82 to determine the role of these residues in the binding of RA. Recombinant wild type and mutant CRABP-II proteins were expressed and purified, and the affinity for retinoids was determined by fluorometric titration and binding of 3H-labeled compounds. K82A displayed an identical Kd for all-trans-RA as wild type CRABP-II and the Kd for all-trans-RA of R111A was only slightly higher. On the other hand, the two Arg132 mutants, R132A and R132Q, of CRABP-II demonstrated undetectable binding of all-trans-RA. Taken together these data demonstrate that Arg132 is a critical amino acid residue for the binding of RA by CRABP-II.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876220     DOI: 10.1074/jbc.270.9.4518

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Mutations affecting the superantigen activity of staphylococcal enterotoxin B.

Authors:  C Briggs; C Garcia; L Zhang; L Guan; J L Gabriel; T J Rogers
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 2.  Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases.

Authors:  Joseph L Napoli
Journal:  Pharmacol Ther       Date:  2017-01-27       Impact factor: 12.310

3.  Studies of the type I cellular retinoic acid-binding protein mutants and their biological activities.

Authors:  L N Wei; L Chang; X HU
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

4.  Analysis of the ligand-binding domain of human retinoic acid receptor alpha by site-directed mutagenesis.

Authors:  F P Lamour; P Lardelli; C M Apfel
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

5.  Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.

Authors:  J B Patel; J Mehta; A Belosay; G Sabnis; A Khandelwal; A M H Brodie; D R Soprano; V C O Njar
Journal:  Br J Cancer       Date:  2007-03-27       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.